Key Takeaways BPC-157 is a synthetic 15-amino-acid peptide (MW 1419.53 Da) with consistent wound-healing and anti-inflammatory signals across rodent models, but zero completed large-scale human RCTs as of mid-2026
Sleep quality and tiredness were measured both objectively (using polysomnography) and subjectively (through self-reports)
Neurobiol Dis 80:6369
Research Dosing, Reconstitution & Handling Considerations Dosing information in the peptide research literature is reported in mg/kg body weight based on animal models, not on standardized human dosing protocols, since neither BPC-157 nor TB-500 is FDA-approved for human use
4b, 5b), however notable conformational differences were observed around residues (acylated K1 Cagri , 14E Cagri , 17R Cagri and 37P Cagri ) that diverge from rAmy and pramlintide, an Amy peptide approved clinically for diabetes 6,7